Felwort

Swertia is a plant traditionally associated with the Himalayan region. While its specific traditional uses are not well-documented, it has been studied for various potential health benefits. Scientific research indicates that Swertia mussotii contains novel compounds such as swertimusins A‒D, which show some anti-inflammatory activity. Additionally, erythrocentaurin from this plant was found to significantly inhibit hepatitis B virus (HBV) replication and reverse 55 metabolites in models, while also suppressing the NF-κB pathway both in vivo and in vitro. Phylogenetic studies using rbcL and trnH-psbA markers have provided reliable species identification for endemic Himalayan plant species, including Swertia mussotii. In a study involving non-alcoholic fatty liver disease (NAFLD) rats, treatment with Swertia mussotii reduced body weight, serum lipids, hepatic lipid accumulation, liver inflammation, and oxidative stress, while also restoring metabolic pathways. No major safety issues or recorded drug interactions have been identified to date.

仅供参考。传统用法并不代表已被证实有效。证据与安全性各不相同，请查阅所引来源。